JohnWendallGoodwinMD

Oncology • Springfield, MO

Physician

Join to view full profile

Dr. Goodwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Goodwin's full profile

Already have an account?

Office
2055 S Fremont Ave
Ste 1000
Springfield, MO 65804
Phone+1 417-820-8099

Fax+1 417-820-8093
Is this information wrong?

Education & Training

University of Kansas School of MedicineResidency, Internal Medicine, 1975 - 1977
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1973 - 1975
University of Kansas School of MedicineInternship, Transitional Year, 1972 - 1973
University of Kansas School of MedicineClass of 1972

Certifications & Licensure

MO State Medical License 1974 - 2023
KS State Medical License 1973 - 2019
ME State Medical License Active through 2012
TX State Medical License 1978 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 3
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers Start of enrollment: 2006 Apr 01
Completed
L-Arginine Supplements in Treating Women Who Are Cancer Survivors Start of enrollment: 2007 May 01
Completed
Not Applicable

Publications & Presentations

PubMed

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Gr...
Goodwin, J. W.,Green, S. J.,Moinpour, C. M.,Bearden, J. D.,Giguere, J. K.,Jiang, C. S.,Lippman, S. M.,Martino, S.,Albain, K. S.> ;J. Clin. Oncol.. 2008 Apr 01
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin JW, Martino S, Albain KS> ;J. Clin. Oncol.. 2008-03-10
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, Petrelli NJ, Findlay MP, Seay TE, Atkins JN, Zapas JL, Goodwin JW, Fehrenbacher L, Ramanathan R...> ;J. Clin. Oncol.. 2007-06-01
Prognostic implication of p53 mutations in HNSCC: Results of Intragroup margin study (E4393).
Poeta LM, Goldwasser MA, Forastiere A, Benoit N, Califano J, Ridge JA, Goodwin J, Kenady D, Sidransky D, Koch WM> ;J. Clin. Oncol.. 2006-06-20
Congestive heart failure (CHF) in older women treated with anthracycline (A) chemotherapy (C).
Giordano SH, Pinder M, Duan Z, Hortobagyi G, Goodwin J> ;J. Clin. Oncol.. 2006-06-20
A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
Xiong HQ, Hess KR, Kayaleh OR, Goodwin JW, Banerjee T, Sinclair SS, Fisch MJ, Wolff RA, Abbruzzese JL> ;J. Clin. Oncol.. 2005-06-01
Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
Royce ME, McGarry W, Bready B, Dakhil SR, Belt RJ, Goodwin JW, Gray R, Hoff PM, Winn R, Pazdur R> ;J. Clin. Oncol.. 1999-10-01
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical ...
Murray N, Livingston RB, Shepherd FA, James K, Zee B, Langleben A, Kraut M, Bearden J, Goodwin JW, Grafton C, Turrisi A, Walde D, Croft H, Osoba D, Ottaway J, Gandara D> ;J. Clin. Oncol.. 1999-08-01
Join now to see all

Hospital Affiliations

Cox Monett HospitalMonett, Missouri
Cox Medical Center BransonBranson, Missouri
Mercy Hospital SpringfieldSpringfield, Missouri